The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

18 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Isoform-Selective and Stereoselective Inhibition of Hypoxia Inducible Factor-2.EBI
University of Texas Southwestern Medical Center
14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) surrogates: carboxylate modifications.EBI
University of Texas Southwestern Medical Center
Discovery of a neuroprotective chemical, (S)-N-(3-(3,6-dibromo-9H-carbazol-9-yl)-2-fluoropropyl)-6-methoxypyridin-2-amine [(-)-P7C3-S243], with improved druglike properties.EBI
University of Texas Southwestern Medical Center
SAR Based Optimization of a 4-Quinoline Carboxylic Acid Analog with Potent Anti-Viral Activity.EBI
University of Texas Southwestern Medical Center
Development of inhibitors of the PAS-B domain of the HIF-2a transcription factor.EBI
University of Texas Southwestern Medical Center
Complexes of bacterial nicotinate mononucleotide adenylyltransferase with inhibitors: implication for structure-based drug design and improvement.EBI
University of Texas Southwestern Medical Center
Investigation of the relative cellular permeability of DNA-binding pyrrole-imidazole polyamides.EBI
University of Texas Southwestern Medical Center
High-throughput evaluation of relative cell permeability between peptoids and peptides.EBI
University of Texas Southwestern Medical Center
Rapid identification of improved protein ligands using peptoid microarrays.EBI
University of Texas Southwestern Medical Center
14,15-Epoxyeicosa-5,8,11-trienoic acid (14,15-EET) surrogates containing epoxide bioisosteres: influence upon vascular relaxation and soluble epoxide hydrolase inhibition.EBI
University of Texas Southwestern Medical Center
A peptoid antagonist of VEGF receptor 2 recognizes a 'hotspot' in the extracellular domain distinct from the hormone-binding site.EBI
University of Texas Southwestern Medical Center
Discovery of small-molecule inhibitors of tyrosinase.EBI
University of Texas Southwestern Medical Center
Novel Bcl-2 Inhibitors Selectively Disrupt the Autophagy-Specific Bcl-2-Beclin 1 Protein-Protein Interaction.EBI
University of Texas Southwestern Medical Center
Discovery of novel TAOK2 inhibitor scaffolds from high-throughput screening.EBI
University of Texas Southwestern Medical Center
Substituted uracils and use thereofBDB
Bayer Pharma Aktiengesellschaft
4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereofBDB
Merck Sharp & Dohme
Spiro-thiazolonesBDB
Hoffmann-La Roche
Quinoxaline inhibitors of phosphoinositide-3-kinases (PI3Ks)BDB
Merck Serono